MabCampath, myeloid cell types, inhibit, lymphocyte depletion, Lemtrada, Inhibitor, FcR, Campath-IH, B cells, Alemtuzumab, CD52, T cells
Alemtuzumab is a humanized monoclonal antibody targeting the CD52 antigen present on lymphocytes. It is widely used in research applications, including in vitro studies of lymphocyte depletion and in vivo models of autoimmune diseases and transplantation immunology.
Konzentration:
10 mg/mL
Molekulargewicht:
146.04 kDa
Reinheit:
98.00% (May vary between batches)
CAS Nummer:
[216503-57-0]
Target-Kategorie:
Others,Apoptosis
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten